NCT05805462 (Euro-CRAFT) is a clinical trial in Coronary Microvascular Disease, sponsored by CoreAalst BV.

Who is sponsoring NCT05805462?

NCT05805462 is sponsored by CoreAalst BV.

What condition does NCT05805462 study?

NCT05805462 studies Coronary Microvascular Disease.

Is NCT05805462 still recruiting?

NCT05805462 is currently active, enrolled. Last updated 12 January 2026.

Last reviewed 2026-01-12 · How we verify

NCT05805462: Euro-CRAFT

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Euro-CRAFT Registry

Active, enrolled Last updated 12 January 2026

What this trial tests

trial in Coronary Microvascular Disease in 671 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline

22 September 2022

Primary endpoint
22 September 2026

22 September 2030

Quick facts

Lead sponsor	CoreAalst BV
Status	Active, enrolled
Study type	OBSERVATIONAL
Enrollment	671
Start date	22 September 2022
Primary completion	22 September 2026
Estimated completion	22 September 2030
Sites	19 locations across Denmark, Netherlands, Belgium, Serbia, United Kingdom, Germany, Switzerland, Spain

Conditions studied

Coronary Microvascular Disease — all drugs for Coronary Microvascular Disease →

Sponsor

CoreAalst BV — full company profile →

Who can join

18 and older, any sex, with Coronary Microvascular Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The Euro-CRAFT Registry is a prospective, multicentric, international registry of patients undergoing functional assessment of the coronary microcirculation using the continuous thermodilution technique. Angina and quality of life questionnaires (Seattle Angina Questionnaire 19 - SAQ19, ORBITA app) will be obtained at baseline, at 6 months, and 1-year follow-up. Clinical follow-up will be performed at 1 year (optionally until 5 years).

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Coronary Microvascular Disease

Currently open trials in the same condition.

NCT06676137 — An Observational Study of Coronary Microvascular Disease of China · recruiting
NCT06529848 — Impact of Exercise Training on Ischemia With Non-Obstructive Coronary Arteries (INOCA): The ExINOCA Study · NA · recruiting
NCT06597851 — Insulin Resistance and Coronary Microvascular Dysfunction in Patients with Myocardial Ischemia and Non-obstructive Coron · NA · recruiting
NCT06699420 — Qishenyiqi Dripping Pill for Coronary Microvascular Disease · Phase 4 · recruiting
NCT06125392 — Multicenter Registry on Microvascular Dysfunction - Searching a New Ach Spasm Definition · recruiting

Other CoreAalst BV trials

Trials by the same sponsor.

NCT06898021 — The 3D Stent Study · recruiting
NCT06205810 — The COMPLETE Study · recruiting
NCT05810051 — Exercise and Coronary Microvascular Disease · NA · active not recruiting
NCT06159231 — FAME II-10-year Follow-Up · completed
NCT05437900 — INSIGHTFUL-FFR Clinical Trial · Phase 4 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05805462 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by CoreAalst BV
Last refreshed: 12 January 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05805462.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing